Literature DB >> 7935849

Biotransformation of locally applied L-dopa in the corpus striatum of the hemi-parkinsonian rat studied with microdialysis.

S Sarre1, N De Klippel, P Herregodts, G Ebinger, Y Michotte.   

Abstract

Microdialysis was used to study the biotransformation of L-dopa in intact and denervated striata of rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the substantia nigra. Microdialysis probes were placed in the intact and in the denervated striatum. Observations were then made on freely moving rats. Extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC) and 4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid; HVA) were monitored before, during and after the local administration of L-dopa via the microdialysis probe for 20 min. A dose-dependent increase in extracellular dopamine levels was seen in intact striatum after application of L-dopa in concentrations ranging between 100 nmol/l and 10 mumol/l. In the denervated striatum, the severity of the lesion influenced dopamine formation, so that no dose-effect relation could be established. The effects of the continuous intra striatal infusion of nomifensine, tetrodotoxin or benserazide on the L-dopa-induced dopamine outflow revealed that in the intact striatum this dopamine release is mainly voltage dependent. It was concluded that in the denervated striatum other cells of non-neuronal origin and containing aromatic L-amino acid decarboxylase make a major contribution to the increase in extracellular dopamine levels. Furthermore, L-dopa itself shows no dopamine-releasing properties, at least under the present experimental conditions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7935849     DOI: 10.1007/bf00180005

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  28 in total

1.  Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis.

Authors:  A Imperato; G Di Chiara
Journal:  Eur J Pharmacol       Date:  1988-11-08       Impact factor: 4.432

2.  Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats.

Authors:  M Santiago; B H Westerink
Journal:  J Neurochem       Date:  1991-09       Impact factor: 5.372

3.  Time course of adaptations in dopamine biosynthesis, metabolism, and release following nigrostriatal lesions: implications for behavioral recovery from brain injury.

Authors:  C A Altar; M R Marien; J F Marshall
Journal:  J Neurochem       Date:  1987-02       Impact factor: 5.372

Review 4.  Is L-dopa an endogenous neurotransmitter?

Authors:  Y Misu; Y Goshima
Journal:  Trends Pharmacol Sci       Date:  1993-04       Impact factor: 14.819

5.  Biotransformation of L-dopa in striatum and substantia nigra of rats with a unilateral, nigrostriatal lesion: a microdialysis study.

Authors:  S Sarre; P Herregodts; D Deleu; A Devrieze; N De Klippel; G Ebinger; Y Michotte
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

6.  Simultaneous microdialysis in striatum and substantia nigra suggests that the nigra is a major site of action of L-dihydroxyphenylalanine in the "hemiparkinsonian" rat.

Authors:  D Orosz; J P Bennett
Journal:  Exp Neurol       Date:  1992-03       Impact factor: 5.330

7.  L-dopa administration enhances exocytotic dopamine release in vivo in the rat striatum.

Authors:  K Koshimura; T Ohue; Y Akiyama; A Itoh; S Miwa
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

8.  Effect of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism: an in vivo microdialysis study comparing normal and 6-hydroxydopamine-lesioned rats.

Authors:  N De Klippel; S Sarre; G Ebinger; Y Michotte
Journal:  Brain Res       Date:  1993-12-10       Impact factor: 3.252

9.  The site of dopamine formation in rat striatum after L-dopa administration.

Authors:  F Hefti; E Melamed; R J Wurtman
Journal:  J Pharmacol Exp Ther       Date:  1981-04       Impact factor: 4.030

10.  Evidence that the substantia nigra is a site of action for L-DOPA.

Authors:  G S Robertson; H A Robertson
Journal:  Neurosci Lett       Date:  1988-06-29       Impact factor: 3.046

View more
  10 in total

1.  Functional regeneration in a rat Parkinson's model after intrastriatal grafts of glial cell line-derived neurotrophic factor and transforming growth factor beta1-expressing extra-adrenal chromaffin cells of the Zuckerkandl's organ.

Authors:  E F Espejo; M C Gonzalez-Albo; J P Moraes; F El Banoua; J A Flores; I Caraballo
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

2.  Effect of pergolide on endogenous and exogenous L-DOPA metabolism in the rat striatum: a microdialysis study.

Authors:  S Dethy; M A Laute; A Luxen; J Hildebrand; S Goldman
Journal:  J Neural Transm Gen Sect       Date:  1995

3.  L-DOPA modulation of corpus striatal dopamine and dihydroxyphenylacetic acid output from intact and 6-OHDA lesioned rats.

Authors:  K Xu; D E Dluzen
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 4.  Presynaptic effects of levodopa and their possible role in dyskinesia.

Authors:  Eugene V Mosharov; Anders Borgkvist; David Sulzer
Journal:  Mov Disord       Date:  2014-12-01       Impact factor: 10.338

Review 5.  Monoamine reuptake inhibitors in Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Parkinsons Dis       Date:  2015-02-25

6.  Dopamine release from serotonergic nerve fibers is reduced in L-DOPA-induced dyskinesia.

Authors:  Nina Nevalainen; Sara Af Bjerkén; Martin Lundblad; Greg A Gerhardt; Ingrid Strömberg
Journal:  J Neurochem       Date:  2011-05-25       Impact factor: 5.372

7.  Entacapone increases and prolongs the central effects of l-DOPA in the 6-hydroxydopamine-lesioned rat.

Authors:  Manfred Gerlach; Maarten van den Buuse; Charles Blaha; Dirk Bremen; Peter Riederer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-10-20       Impact factor: 3.000

Review 8.  Contribution of serotonergic transmission to the motor and cognitive effects of high-frequency stimulation of the subthalamic nucleus or levodopa in Parkinson's disease.

Authors:  Sylvia Navailles; Philippe De Deurwaerdère
Journal:  Mol Neurobiol       Date:  2012-01-06       Impact factor: 5.590

9.  Biotransformation of locally applied precursors of dopamine, serotonin and noradrenaline in striatum and hippocampus: a microdialysis study.

Authors:  S Sarre; I Smolders; K Thorré; G Ebinger; Y Michotte
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

10.  Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia.

Authors:  Sylvia Navailles; Philippe De Deurwaerdère
Journal:  Parkinsons Dis       Date:  2011-10-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.